AMBS Stock | News | Quote | Stock Forum | Thursday, December

New Post Public Reply Private Reply Replies (0) Message Board

Dec 26, 2013 at 5:25 PM

$AMBS Amarantus Bioscience Holdings, Inc. AMBS Company Overview

Amarantus Bioscience Holdings, Inc. AMBS Current Price and Quotes
Last Price 0.066
Previous Close 0.054 Open 0.0549
Daily Range 0.0675 - 0.0545 52wk Range 0.195 - 0.027
Volume 10,599,173 Dividend N/A
Average Vol (3m) 3,489,000 Yield N/A

AMBS Stock Message Board http://investorshangout.com/search?q=AMBS&...mp;yt1=Go!

Last Updated: Thursday, December 26, 2013 5:25:14 PM

Amarantus Bioscience Holdings, Inc. AMBS
Company Information

675 Almanor Ave
Sunnyvale, CA

Website: http://www.amarantus.com
Phone: 408-737-2734
Email: gerald@amarantus.com
Find us on:

Amarantus Bioscience Holdings, Inc. AMBS
Amarantus BioScience, Inc. is a development-stage biotechnology company founded in January 2008. The Company is focused on developing unique products and proprietary technologies for the potential treatment and/or diagnosis of Parkinson's disease, Alzheimer's disease, Traumatic Brain Injury, Ischemic Heart Disease and other human diseases. The Company owns the intellectual property rights to Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF") and is developing MANF-based products as tr...

Amarantus Bioscience Holdings, Inc. AMBS
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Sep 30, 2013 10-Q
CIK 0001424812
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o Nov 19, 2012
Incorporated In: NV, USA
Year of Inc. 2008
Employees 3 a/o Nov 19, 2012
Company Officers/Contacts

Gerald E. Commissiong CEO, President, COO
Marc E. Faerber CFO, Treasurer, Secretary
John W. Commissiong CSO
Company Directors

Mark Benedyk
Gerald E. Commissiong
John W. Commissiong
Robert L. Harris
David A. Lowe
Company Notes

Formerly=Amarantus Bioscience, Inc. until 4-2013
Formerly=Amarantus Biosciences, Inc. until 12-2012
Formerly=Jumpkicks, Inc. until 6-2011
Service Providers

Auditor/Accountant
Silberstein Ungar, PLLC
30600 Telegraph Rd.
Suite 2175
Bingham Farms, MI, 48025
United States

Legal Counsel
Sichenzia Ross Friedman Ference LLP
61 Broadway
New York, NY, 10006
United States

Investor Relations Firm
LHA Inc.
800 Third Ave.
New York, NY, 10022
United States

Amarantus Bioscience Holdings, Inc. AMBS
AMBS Security Details

Share Structure

Market Value1 $29,777,965 a/o Dec 24, 2013
Shares Outstanding 551,443,794 a/o Nov 13, 2013
Float Not Available
Authorized Shares 1,000,000,000 a/o Nov 14, 2012
Par Value 0.001
Shareholders

Shareholders of Record 64 a/o Apr 26, 2013
Corporate Actions

Ex. Date Record Date Pay Date
Dividend (0.00) Jun 14, 2011 Jun 06, 2011 Jun 13, 2011
Security Notes

Capital Change=shs increased by 25 for 1 split. Ex-date=06/14/2011. Rec date=06/06/2011. Pay date=06/13/2011.
Short Selling Data

Short Interest 7,350 (-88.62%)
Dec 13, 2013
Significant Failures to Deliver No
Transfer Agent(s)

VStock Transfer

Amarantus Bioscience Holdings, Inc. AMBS Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Oct 31, 2010
Total Revenue - 224 192 -
Cost of Revenue - - - -
Gross Profit - 224 192 -
Operating Expenses

Research and Development 584 1,178 490 -
Sales, General and Admin. 3,506 2,786 924 57
Non-Recurring Items - - - -
Other - - - 1
Operating Income (4,090) (3,740) (1,223) (59)
Income From Continuing Operations

Add'l Income/Expense Items 473 315 94 -
Earnings Before Interest and Tax (3,617) (3,425) (1,128) (59)
Interest Expense 1,518 1,015 79 -
Earnings Before Tax (5,136) (4,440) (1,208) (59)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (5,136) (4,440) (1,208) (59)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (5,136) (4,440) (1,208) (59)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (5,136) (4,440) (1,208) (59)

Amarantus Bioscience Holdings, Inc. AMBS Recent News

Dec 18, 2013 Amarantus Licenses MANF-Related Wolfram's and Diabetes Therapeutic and Diagnostic Intellectual Property From University of Massachusetts Medical School
Dec 17, 2013 Amarantus and Brewer Sports Announce ONE MIND for Research at 2nd #C4CT Concussion Awareness Summit Prior to Super Bowl XLVIII at United Nations
Dec 3, 2013 Amarantus Obtains Exclusive Option to License University of Miami Bascom Palmer Eye Institute's Intellectual Property for the Treatment of Retinal Diseases Using MANF and CDNF
Nov 26, 2013 Amarantus BioScience to Present at the LD Micro Sixth Annual Conference on December 3, 2013
Nov 14, 2013 Amarantus Reports Third Quarter 2013 Financial Results and Development Progress
Nov 14, 2013 Exclusive Insight on ITEN, MSLP and AMBS
Nov 13, 2013 Amarantus and Brewer Sports Announce 2nd #C4CT Concussion Awareness Summit Surrounding Super Bowl XLVIII
Nov 12, 2013 Amarantus BioScience CSO Publishes New Blog Entitled "The Golden Goose: Preparing PhenoGuard to Lay the Next Golden Egg"
Nov 8, 2013 Stocks Under Review - WTER, BRGO, AMBS and TDEY
Nov 6, 2013 Amarantus Appoints David A. Lowe, PhD to Board of Directors

1
2
next >

AMBS Amarantus Bioscience Holdings, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=AMBS&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/AMBS/quote
Stock Chart http://www.otcmarkets.com/stock/AMBS/chart
Company Info http://www.otcmarkets.com/stock/AMBS/company-info
Recent News http://www.otcmarkets.com/stock/AMBS/news
Financials http://www.otcmarkets.com/stock/AMBS/financials
Filings and Disclosure http://www.otcmarkets.com/stock/AMBS/filings
Short Sales http://www.otcmarkets.com/stock/AMBS/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/AMBS/insider-transactions
Research Reports http://www.otcmarkets.com/stock/AMBS/research
Summary http://finance.yahoo.com/q?s=AMBS
Historical Prices http://finance.yahoo.com/q/hp?s=AMBS+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=AMBS
Basic Chart http://finance.yahoo.com/q/bc?s=AMBS+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=AMBS+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=AMBS+Headlines
Press Releases http://finance.yahoo.com/q/p?s=AMBS+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=AMBS+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=AMBS+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=AMBS+Industry
Major Holders http://finance.yahoo.com/q/mh?s=AMBS+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=AMBS+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=AMBS+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=AMBS
Balance Sheet http://finance.yahoo.com/q/bs?s=AMBS
Cash Flow http://finance.yahoo.com/q/cf?s=AMBS+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/AMBS
Market Watch http://www.marketwatch.com/investing/stock/AMBS
Bloomberg http://www.bloomberg.com/quote/AMBS:US
Morningstar http://quotes.morningstar.com/stock/s?t=AMBS
Bussinessweek http://investing.businessweek.com/research/st...icker=AMBS
Barchart http://www.barchart.com/quotes/stocks/AMBS
OTC Short Report http://otcshortreport.com/index.php?index=AMBS
Investopedia http://www.investopedia.com/markets/stocks/AMBS/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Recovery 180's Landmark Facility: Community Impact Unfolds

Taneytown Takes a Significant Leap Well, Taneytown's making noise, folks. Never thought this sleepy spot would pull off something so important, but here we are with Recovery 180 opening Taneytown’s first-ever residential Level 3.1 treatment facility. After four years of struggle, the largest venture in Carroll County is opening its doors to residents who desperately...

IAN Aims to Redefine Longevity, Unveils Health Gummies

New Chapter in Wellness: Welcome IAN Here's a kicker for you—IAN, a fresh face in the bustling wellness arena, is setting out to change how we look at aging. Founded by Richard Laver, who's been around the block with some heavy hitters like Kate Farms, IAN is making its mark with a unique product—a daily stack gummy launching this December 22. This isn't your...

MedStar's Non-Invasive Tech Shakes Up Treatment World

Incisionless Relief: A New Dawn for Neurological Care? Imagine being able to shed a neurological burden with nothing more than sound waves. That's exactly where we're heading with MedStar Health's latest offering. They're rolling out incisionless, MRI-guided ultrasound technology targeting essential tremor and Parkinson's disease. This isn't just tinkering under the hood;...

Tenax Sued: Investors Face Class Action Over TNX-103

What Tenax Investors Need to Know Alright, folks, time to pull up a chair and pay attention to what's brewing with Tenax Therapeutics—yeah, we're talking NASDAQ: TENX. The company's head is spinning as it's caught up in a securities class action lawsuit. What's the fuss? The fine print here accuses Tenax of misleading investors about the effectiveness of their product,...

Pinterest Faces Legal Probe: Investor Concerns Rise

Legal Storms Gather on Pinterest's Horizon I remember a time when Pinterest was the darling of Wall Street, but here we are, staring at an investigation that's got more layers than an onion. On November 6, 2026, news broke that Kahn Swick & Foti, LLC (KSF) is sniffing around Pinterest's officers and directors. This is no small fry since KSF is steered by none other than...

Mount St. Mary’s University Secures Future for High Schoolers

Breaking Ground: Education Made Accessible Boy, oh boy, this move between Mount St. Mary’s University and Saint John Vianney High School is something that just warmed up my trading heart like a surprise market rally. They've inked a deal—a Memorandum of Understanding (MOU)—to fling open the doors to higher education for high schoolers who've got their eyes on the...

Alfa Laval's Bold Move: Snapping Up NAVTOR for $700M

The Seismic Shift in Maritime Solutions Alfa Laval's decision to acquire NAVTOR for a massive $700 million in cash throws down a marker in the maritime domain. This isn't some casual, "let's test the waters" thing; it's the kind of big-money play we all sit up and notice. You're talking about Alfa Laval trying to mold the digital side of their maritime offerings, right...

Cavli's Latest Innovations Shine at electronica 2026

Cavli Wireless: Paving the Path for Smarter IoT There's a storm brewing in Munich at electronica 2026, and Cavli Wireless is the name spurred across tech-savvy lips. With their latest revelation—the P16QS LTE Cat 1bis module and Cortex AI—the firm’s tossing bold challenges at the IoT and AI landscape. It's a gutsy move, cementing their role as a frontier pusher in a...

Bark Tech Expands Disability Access with New Approvals

Redefining Accessibility through Technology Tech giant Bark is making waves with its fresh blueprint for accessible technology. Recently, Wisconsin gave a nod to Bark Phone and Bark Watch through the state’s IRIS and CLTS programs, aiming to support individuals with disabilities. This development could reshape our understanding of technology beyond the binary choice of...

Preventing Dental Issues in Kids: Valuable Tips Shared

Pediatric Dental Challenges Under the Microscope When it comes to kids and dental health, we're talking about the fundamentals—the kind that sticks around and makes a difference in their future pearly whites. None of that flashy tech gizmo stuff, just straight-on strategies for resilient chompers. Cavities, gum irritation, early tooth alignment—these are the everyday...